Glenn E. Bigsby

724 total citations
19 papers, 512 citations indexed

About

Glenn E. Bigsby is a scholar working on Obstetrics and Gynecology, Reproductive Medicine and Surgery. According to data from OpenAlex, Glenn E. Bigsby has authored 19 papers receiving a total of 512 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Obstetrics and Gynecology, 11 papers in Reproductive Medicine and 6 papers in Surgery. Recurrent topics in Glenn E. Bigsby's work include Endometrial and Cervical Cancer Treatments (10 papers), Uterine Myomas and Treatments (9 papers) and Endometriosis Research and Treatment (6 papers). Glenn E. Bigsby is often cited by papers focused on Endometrial and Cervical Cancer Treatments (10 papers), Uterine Myomas and Treatments (9 papers) and Endometriosis Research and Treatment (6 papers). Glenn E. Bigsby collaborates with scholars based in United States, Germany and Italy. Glenn E. Bigsby's co-authors include Robert W. Holloway, Sarfraz Ahmad, Neil J. Finkler, Dirk Pikaart, Lorna A. Brudie, James E. Kendrick, Nicole M. Stavitzski, Sarika Gupta, David M. O’Malley and David E. Cohn and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Annals of Surgical Oncology.

In The Last Decade

Glenn E. Bigsby

18 papers receiving 502 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Glenn E. Bigsby United States 9 413 257 163 55 52 19 512
Gali Lev United States 5 301 0.7× 207 0.8× 102 0.6× 98 1.8× 26 0.5× 5 448
Mariano Catello Di Donna Italy 11 168 0.4× 147 0.6× 127 0.8× 34 0.6× 37 0.7× 31 302
Patrizia De Marzi Italy 10 178 0.4× 177 0.7× 90 0.6× 37 0.7× 42 0.8× 17 329
Thomas Hébert France 9 158 0.4× 127 0.5× 121 0.7× 21 0.4× 39 0.8× 33 287
Maija Lavonius Finland 13 122 0.3× 240 0.9× 423 2.6× 7 0.1× 116 2.2× 19 566
André Lopes Brazil 9 81 0.2× 81 0.3× 97 0.6× 24 0.4× 51 1.0× 30 226
Izumi Togami Japan 10 70 0.2× 38 0.1× 87 0.5× 79 1.4× 88 1.7× 35 319
Katrijn Michielsen Belgium 7 128 0.3× 208 0.8× 166 1.0× 33 0.6× 64 1.2× 7 406
M. Lahousen Austria 10 87 0.2× 195 0.8× 133 0.8× 20 0.4× 51 1.0× 27 307
Vladislav Braşoveanu Romania 14 34 0.1× 123 0.5× 278 1.7× 50 0.9× 124 2.4× 60 390

Countries citing papers authored by Glenn E. Bigsby

Since Specialization
Citations

This map shows the geographic impact of Glenn E. Bigsby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Glenn E. Bigsby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Glenn E. Bigsby more than expected).

Fields of papers citing papers by Glenn E. Bigsby

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Glenn E. Bigsby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Glenn E. Bigsby. The network helps show where Glenn E. Bigsby may publish in the future.

Co-authorship network of co-authors of Glenn E. Bigsby

This figure shows the co-authorship network connecting the top 25 collaborators of Glenn E. Bigsby. A scholar is included among the top collaborators of Glenn E. Bigsby based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Glenn E. Bigsby. Glenn E. Bigsby is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Holloway, Robert W., et al.. (2019). A prospective randomized trial of intravenous ketorolac vs. acetaminophen administered with opioid patient-controlled analgesia in gynecologic surgery. Gynecologic Oncology. 155(3). 468–472. 8 indexed citations
2.
Holloway, Robert W., Sarfraz Ahmad, James E. Kendrick, et al.. (2017). A Prospective Cohort Study Comparing Colorimetric and Fluorescent Imaging for Sentinel Lymph Node Mapping in Endometrial Cancer. Annals of Surgical Oncology. 24(7). 1972–1979. 50 indexed citations
3.
Holloway, Robert W., Sarika Gupta, Nicole M. Stavitzski, et al.. (2016). Sentinel lymph node mapping with staging lymphadenectomy for patients with endometrial cancer increases the detection of metastasis. Gynecologic Oncology. 141(2). 206–210. 97 indexed citations
4.
Holloway, Robert W., Sarfraz Ahmad, James E. Kendrick, et al.. (2016). A prospective randomized trial comparing colorimetric and fluorescent imaging for pelvic sentinel lymph node mapping in endometrial cancer. Gynecologic Oncology. 141. 206–206.
5.
Amirkhosravi, Ali, Glenn E. Bigsby, Liza Robles‐Carrillo, et al.. (2013). Blood clotting activation analysis for preoperative differentiation of benign versus malignant ovarian masses. Blood Coagulation & Fibrinolysis. 24(5). 510–517. 17 indexed citations
6.
7.
Brudie, Lorna A., Floor Backes, Sarfraz Ahmad, et al.. (2012). Analysis of disease recurrence and survival for women with uterine malignancies undergoing robotic surgery. Gynecologic Oncology. 128(2). 309–315. 33 indexed citations
8.
Backes, Floor, Lorna A. Brudie, M. Ryan Farrell, et al.. (2012). Short- and long-term morbidity and outcomes after robotic surgery for comprehensive endometrial cancer staging. Gynecologic Oncology. 125(3). 546–551. 47 indexed citations
9.
Brudie, Lorna A., Giorgia Gaia, Sarfraz Ahmad, et al.. (2011). Peri-operative outcomes of patients with stage IV endometriosis undergoing robotic-assisted laparoscopic surgery. Journal of Robotic Surgery. 6(4). 317–322. 15 indexed citations
10.
Brudie, Lorna A., Floor Backes, Sarfraz Ahmad, et al.. (2011). Survival outcomes for women with uterine malignancy undergoing robot-assisted laparoscopic staging procedures. Gynecologic Oncology. 120. S95–S95. 1 indexed citations
11.
Bigsby, Glenn E., et al.. (2011). Chemoradiation with adjuvant hysterectomy for stage IB-2 cervical cancer: a 10-year experience. Gynecological Surgery. 9(3). 327–333. 1 indexed citations
12.
Holloway, Robert W., Sarfraz Ahmad, Glenn E. Bigsby, et al.. (2011). Benchmarking Robotic Surgical Performance: A 4-Year Analysis of Annual Peri-Operative Outcomes for Patients with Endometrial Cancer Treated with Robotic-Assisted Laparoscopic Hysterectomy and Staging Lymphadenectomy. Journal of Minimally Invasive Gynecology. 18(6). S159–S160. 1 indexed citations
13.
Holloway, Robert W., et al.. (2009). Robotic-assisted laparoscopic hysterectomy and lymphadenectomy for endometrial cancer: Analysis of surgical performance. Gynecologic Oncology. 115(3). 447–452. 75 indexed citations
14.
Holloway, Robert W., et al.. (2008). Robotically assisted laparoscopic hysterectomy versus total abdominal hysterectomy and lymphadenectomy for endometrial cancer. Gynecologic Oncology. 111(3). 412–417. 139 indexed citations
15.
Holloway, Robert W., et al.. (2006). Alpha-Fetoprotein-Producing Serous Carcinoma of the Uterus Metastasizing to the Ovaries, Mimicking Primary Ovarian Yolk Sac Tumor. International Journal of Gynecological Pathology. 26(1). 66–70. 8 indexed citations
16.
Amirkhosravi, Ali, Glenn E. Bigsby, Mildred Amaya, et al.. (2006). Hypercoagulability in Ovarian Cancer Revisited: A Prospective Analysis of Coagulation and Platelet Activation Markers.. Blood. 108(11). 1762–1762. 1 indexed citations
17.
Bigsby, Glenn E., et al.. (2005). Endometroid adenocarcinoma of the uterus with cardiac metastasis. Gynecologic Oncology. 97(1). 256–259. 7 indexed citations
18.
Finkler, N., et al.. (2004). Doxil and gemcitabine combination therapy for recurrent ovarian cancer: Results of a phase II trial. Journal of Clinical Oncology. 22(14_suppl). 5090–5090. 4 indexed citations
19.
Finkler, N., et al.. (2004). Doxil and gemcitabine combination therapy for recurrent ovarian cancer: Results of a phase II trial. Journal of Clinical Oncology. 22(14_suppl). 5090–5090. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gali Lev Breakdown of academic impact, for papers by Mariano Catello Di Donna Breakdown of academic impact, for papers by Patrizia De Marzi Breakdown of academic impact, for papers by Thomas Hébert Breakdown of academic impact, for papers by Maija Lavonius Breakdown of academic impact, for papers by André Lopes Breakdown of academic impact, for papers by Izumi Togami Breakdown of academic impact, for papers by Katrijn Michielsen Breakdown of academic impact, for papers by M. Lahousen Breakdown of academic impact, for papers by Vladislav Braşoveanu
Rankless by CCL
2026